GGrantIndex
← Search

ORAL PENTOXIFYLLINE IN CHILDREN WITH ACUTE KAWASAKI DIS.

$0M01FY2000RRNIH

University Of California San Diego, La Jolla CA

Investigators

Linked publications & trials

Abstract

Evaluate the pharmacokinetics and safety of a new oral syrup of pentoxifylline as a adjunct to intravenous immunoglobulin and aspirin in the treatment of Kawasaki disease and assess the clinical and laboratory evidence of toxicity of pentoxifylline.

View original record on NIH RePORTER →